Exclusive

Publication

Byline

मंत्री बनने पर लोजपा कार्यकर्ताओं में हर्ष, दी बधाई

अररिया, मई 9 -- फारबिसगंज, एक संवाददाता। लोजपा (रामविलास) आईटी सेल के जिलाध्यक्ष अमित कुमार पासवान ने संजय सिंह एवं संजय पासवान को बिहार सरकार में मंत्री बनाए जाने पर बधाई दी है। उन्होंने कहा कि दोनों... Read More


Assam Career 2026 : Assam Cricket Association Recruitment

Guwahati, May 9 -- Applications are invited for recruitment of various coaching and technical positions or career in Assam Cricket Association in 2026. Assam Cricket Association is inviting applicati... Read More


Les Émirats arabes unis injectent 49 milliards $ pour accélérer l’essor de l’industrie locale

Chad, May 9 -- Les Émirats arabes unis vont localiser plus de 5 000 produits dans le cadre de leur stratégie de souveraineté industrielle, a annoncé le ministre de l’Industrie et des Technologies avan... Read More


Singapore Clinical Trial: Responses Against Paramyxoviruses in T cells with crOss Reactivity

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other rel... Read More


Singapore Clinical Trial: Effect of innate immune reprogramming by primary dengue on host response to secondary dengue

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The f... Read More


Singapore Clinical Trial: Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voiding: A case controlled study

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voidi... Read More


Singapore Clinical Trial: An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembro... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More


Singapore Clinical Trial: A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in patients with systemic sclerosis (SSc)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nera... Read More